Minneapolis, MINNESOTA22 Active Studies

Rheumatoid Arthritis Clinical Trials in Minneapolis, MINNESOTA

Find 22 actively recruiting rheumatoid arthritis clinical trials in Minneapolis, MINNESOTA. Connect with local research sites and explore new treatment options.

22
Active Trials
19
Sponsors
64,984
Enrolling

Recruiting Rheumatoid Arthritis Studies in Minneapolis

RecruitingMinneapolis, MINNESOTANCT00785525

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

The purpose of the study is to: * Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors * Assess t...

60,000 participants
Center for International Blood and Marrow Transplant Research
View Study Details
RecruitingMinneapolis, MINNESOTANCT05958342

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to...

1,050 participants
Jason Sperry
View Study Details
RecruitingMinneapolis, MINNESOTANCT07006675

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

Two arm, pragmatic, randomized controlled multicenter Phase III noninferiority trial evaluating the efficacy of standard pain management without NSAIDs (Group 1) vs. standard pain management plus up t...

1,000 participants
Major Extremity Trauma Research Consortium
View Study Details
RecruitingMinneapolis, MINNESOTANCT06994442

Optimizing Pain Treatment in Children On Mechanical Ventilation

In this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help wit...

644 participants
Weill Medical College of Cornell University
View Study Details
RecruitingMinneapolis, MINNESOTANCT03922724

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Background: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause. Objective:...

330 participants
National Cancer Institute (NCI)
View Study Details
RecruitingMinneapolis, MINNESOTANCT05707377

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

The primary objectives of this study are: In Part 1 to evaluate the efficacy of zanubrutinib as measured by proteinuria reduction, and in Part 2 to evaluate the efficacy of zanubrutinib compared with ...

282 participants
BeiGene
View Study Details
RecruitingMinneapolis, MINNESOTANCT05442567

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this...

240 participants
Takeda
View Study Details
RecruitingMinneapolis, MINNESOTANCT06032065

SMART Exercise for PAD

Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lowe...

210 participants
Northwestern University
View Study Details
RecruitingMinneapolis, MINNESOTANCT02407028

Hyperbaric Oxygen Brain Injury Treatment Trial

The purpose of this innovative adaptive phase II trial design is to determine the optimal combination of hyperbaric oxygen treatment parameters that is most likely to demonstrate improvement in the ou...

200 participants
Hennepin Healthcare Research Institute
View Study Details
RecruitingMinneapolis, MINNESOTANCT04794530

The COCOA-PAD II Trial

Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less...

190 participants
Northwestern University
View Study Details
RecruitingMinneapolis, MINNESOTANCT05535166

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99 years of age with newly diagnosed medul...

120 participants
St. Jude Children's Research Hospital
View Study Details
RecruitingMinneapolis, MINNESOTANCT07116499

A Study of K-645 in the Treatment of Multiple Migraine Attacks

This is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the treatment of patient...

120 participants
Kallyope Inc.
View Study Details
RecruitingMinneapolis, MINNESOTANCT06144645

A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS

The goal of the VNS4PWS clinical study is to test the efficacy, safety, and acceptability of transcutaneous vagus nerve stimulation (tVNS) treatment in people with PWS....

102 participants
Foundation for Prader-Willi Research
View Study Details
RecruitingMinneapolis, MINNESOTANCT05654922

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

The goal of this Phase 3 clinical trial is to compare ARINA-1 (a nebulized immunomodulatory agent) plus Standard of Care vs Standard of Care alone. The main question it aims to answer are: * Evaluate...

100 participants
Renovion, Inc.
View Study Details
RecruitingMinneapolis, MINNESOTANCT06665100

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity of lung infections in patients with hemat...

100 participants
Pulmotect, Inc.
View Study Details
RecruitingMinneapolis, MINNESOTANCT07197034

The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial

The goal of this clinical trial is to learn if ARD-101 works to treat hyperphagia-related behavior in patients with Prader-Willi syndrome (PWS) when used in a long term setting. It will also teach us ...

90 participants
Aardvark Therapeutics, Inc.
View Study Details
RecruitingMinneapolis, MINNESOTANCT05465174

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

The current study assesses the tolerability and efficacy of monotherapy with pan-RAF-kinase (Tovorafenib) inhibition for the treatment of children and young adults with craniopharyngioma....

57 participants
Sabine Mueller, MD, PhD
View Study Details
RecruitingMinneapolis, MINNESOTANCT04774718

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors

This study will evaluate the safety, pharmacokinetics, and efficacy of alectinib in children and adolescents with ALK fusion-positive solid or CNS tumors for whom prior treatment has proven to be inef...

42 participants
Hoffmann-La Roche
View Study Details
RecruitingMinneapolis, MINNESOTANCT05714969

A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The main aim of this study is to determine the percentage of participants with a clinical (Part 1)...

33 participants
Takeda
View Study Details
RecruitingMinneapolis, MINNESOTANCT07157787

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

The primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease progression using 24-hour urine protein cr...

30 participants
Alexion Pharmaceuticals, Inc.
View Study Details
RecruitingMinneapolis, MINNESOTANCT05582993

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

The main aim of the study is to evaluate the effectiveness of prophylaxis with vonicog alfa (recombinant von Willebrand factor \[rVWF\]) in children. This study will enroll those participants who have...

24 participants
Takeda
View Study Details
RecruitingMinneapolis, MINNESOTANCT06321601

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV....

20 participants
Amgen
View Study Details

About Rheumatoid Arthritis Clinical Trials in Minneapolis

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 22 rheumatoid arthritis clinical trials recruiting participants in Minneapolis, MINNESOTA. These studies are seeking a combined 64,984 participants. Research is being sponsored by Center for International Blood and Marrow Transplant Research, Jason Sperry, Major Extremity Trauma Research Consortium and 16 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Minneapolis — FAQ

Are there rheumatoid arthritis clinical trials in Minneapolis?

Yes, there are 22 rheumatoid arthritis clinical trials currently recruiting in Minneapolis, MINNESOTA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 22 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated March 2, 2026 from ClinicalTrials.gov